2007
DOI: 10.1111/j.1742-6723.2007.01028.x
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine‐induced complete heart block: Not so transient

Abstract: Adenosine is a purine nucleoside widely used to terminate supraventricular tachycardias, and as a diagnostic adjunct in narrow complex regular tachycardia of uncertain origin. Atrioventricular blockade and bradyarrhythmias following administration are common but generally short-lived. We report a case of prolonged complete heart block requiring intubation and temporary pacing, following adenosine administration in atrial flutter treated with combination metoprolol and diltiazem.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…2 In addition, it has an ultrashort half-life making it essentially of no use for patients with multiple recurring SVTs, an SVT recurrence rate of 9-57%, pro-arrhythmic effect with rare but potentially lethal polymorphic ventricular tachycardia, bronchospasm and a reported dose dependent efficacy between 70% and 95%. [2][3][4][5] Verapamil and diltiazem have also been associated with adverse effects, including ventricular dysfunction, hypotension, and cardiovascular collapse particularly when given in infants and neonates. [6][7][8] Dexmedetomidine an alpha-2 adrenoreceptor agonist with primary sedative properties has recently been shown to have potential antiarrhythmic effects.…”
Section: R Eentrant Supraventricular Tachycardia (Svt)mentioning
confidence: 99%
“…2 In addition, it has an ultrashort half-life making it essentially of no use for patients with multiple recurring SVTs, an SVT recurrence rate of 9-57%, pro-arrhythmic effect with rare but potentially lethal polymorphic ventricular tachycardia, bronchospasm and a reported dose dependent efficacy between 70% and 95%. [2][3][4][5] Verapamil and diltiazem have also been associated with adverse effects, including ventricular dysfunction, hypotension, and cardiovascular collapse particularly when given in infants and neonates. [6][7][8] Dexmedetomidine an alpha-2 adrenoreceptor agonist with primary sedative properties has recently been shown to have potential antiarrhythmic effects.…”
Section: R Eentrant Supraventricular Tachycardia (Svt)mentioning
confidence: 99%
“…Adenosine is also capable to induce an impaired or blocked of atrioventricular nodal conduction in humans [42,46]. This is generally a short-lived, not too serious, adverse reaction, but prolonged complete heart block requiring intubation and temporary pacing has also been reported [47]. A 1 adenosine receptors are abundantly expressed in the AV junction.…”
Section: Basic Studies On Acute Actions Of Methylxanthines and Other mentioning
confidence: 99%
“…Various have been reported in up to 13% of patients treated with adenosine, including prolonged AV block, paroxysmal atrial fibrillation, non‐ventricular tachycardia, transient premature ventricular complexes, torsades de points with prolonged QT syndrome and rapid atrial fibrillation or flutter 60–69 . Most of these arrhythmias are transient and recover spontaneously but, as noted above, there are case reports of life‐threatening tachyarrhythmias in patients with pre‐excited atrial fibrillation, and prolonged bradycardia in patients on concurrent AV blocking drugs 35,69,70 …”
Section: Side‐effectsmentioning
confidence: 99%
“…[60][61][62][63][64][65][66][67][68][69] Most of these arrhythmias are transient and recover spontaneously but, as noted above, there are case reports of life-threatening tachyarrhythmias in patients with pre-excited atrial fibrillation, and prolonged bradycardia in patients on concurrent AV blocking drugs. 35,69,70 Minor Non-life-threatening but unpleasant side-effects of dyspnoea, chest pain, flushing and headache occur in approximately 10% of patients. These are self-limiting and patients' recall of these can be reduced with the use of midazolam.…”
Section: Dose and Administrationmentioning
confidence: 99%